Teva/Mylan Deal Doesn’t Stir Pharma ETFs
On a down day for U.S. stocks, even the latest rumor of a mega pharmaceuticals…
Browsing: Israel
Pharma Focus Fabulous for Israel ETFs
Increased mergers and acquisitions in the pharmaceuticals space has been a boon for healthcare-heavy Israel…
Central Bank Rate Cut, Loose Policies to Bolster Israel ETFs
The Israeli markets and related exchange traded funds could begin to strengthen after the Bank…
Israel’s Resilience, Fundamentals Keep This ETF Sturdy
Amid events including military conflicts in Gaza and Ukraine, and the beheadings of three journalists…
Tel Aviv Shake-Up Could Bring Israel to MSCI Europe ETFs
In an attempt to gain acceptance into broad MSCI Inc. (NYSE: MSCI) Europe indices, and…
Geopolitical Uncertainty Weighs on Israel ETFs
Geopolitical volatility and uncertainty has riled global markets this year, with the most recent skirmishes…
Israel Intrigue With ETFs
Since MSCI promoted Israel to developed market status, the country has not seen its status…
Momentum With Israel ETFs
Since the start of 2013, several notable developed markets have taken turns being momentum plays.…
Illuminating Israel ETFs
Since MSCI promoted Israel to developed market status, many investors pared exposure to the country.…
Teva Takeover Would Send This ETF Soaring
With mergers and acquisitions activity on the uptick, the familiar question of “Who is next?”…
Israel’s Booming Startup Scene Could Lift This ETF
This might go down as the year of U.S. stocks and the resurgence of some…
ETF Spotlight: Market Vectors Israel
ETF Spotlight on the Market Vectors Israel ETF (NYSEArca: ISRA), part of an ongoing series.…
Israel, Middle East ETFs Dragged Down by Syria Tensions
August was the worst month for U.S. stocks since May 2012 and the worst month…
Investors Get Another ETF for Israel
Van Eck Global’s ETF unit Market Vectors on Wednesday introduced a new fund designed to…